Program
NOVEMBER 8th - Friday
8:30-8:40 AM
WELCOME & OPENING
8:40-9:00 AM
EDUCATIONAL SESSION
Liquid biopsies: types, applications and perspectives in Oncology
Dr. Ludmilla Chinen - A. C. Camargo Cancer Center, São Paulo, Brazil
9:00 - 10:10 AM
MAJOR SESSION: CIRCULATING TUMOR CELLS (CTCs)
Overview of CTCs: approaches, disease monitoring and early detection of cancer and use in clinical practice in Europe
Dr. Catherine Alix-Panabières - University of Montpellier, Montpellier, France
Circulating Tumor Cells in disease follow-up of patients with diverse solid tumors
Dr. Ludmilla Chinen - A.C. Camargo Cancer Center, São Paulo, Brazil
Discussion
10:10-10:40 AM
COFFEE-BREAK & NETWORKING
10:40-11:50 AM
MAJOR SESSION: EXOSOMES AS LIQUID BIOPSY
Detection of BRAFV600E mutation in lymphatic drainage-derived extracellular vesicles as prognostic factor and residual disease indicator in melanoma
Dr. Susana García-Silva – CNIO, Madrid, Spain
Liquid biopsies components as surrogates for cancer treatment response
Dr. Diana Noronha Nunes – A. C. Camargo Cancer Center, São Paulo, Brazil
Discussion
11:50-12:40 PM
MAJOR SESSION: CIRCULATING NON-CODING RNAs
Circulating non-coding RNAs as tumor biomarkers
Dr. Miriam Galvonas Jasiulionis – Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
Circulating microRNAs as potential biomarkers for early detection of lung cancer
Dr. Patrícia Pintor dos Reis – Universidade Estadual Paulista (UNESP), Botucatu, Brazil
Discussion
12:40-2:30 PM
COMPLIMENTARY LUNCH
The growing relevance of liquid biopsy in clinical research: available technologies and recent advances
Beatriz Pinto - Thermo Fisher Scientific, São Paulo, Brazil
Discussion
2:30-3:20 PM
MAJOR SESSION: CIRCULATING TUMOR DNAs (ctDNAs) - CLINICAL APPLICATIONS
Could circulating tumor DNA underpin the precision medicine?
Dr. Danielle Calcagno - Universidade Federal do Pará (UFPA), Belém, Brazil
The use of ctDNA in the clinical practice in lung cancer
Dr. Aknar Calabrich – Clínica AMO (Assistência Multidisciplinar em Oncologia), Salvador, Brazil
Discussion
3:20 - 4:00 PM
COFFEE-BREAK & NETWORKING
4:00-4:50 PM
MAJOR SESSION: CIRCULATING TUMOR DNAs (ctDNAs) - DETECTION AND CHALLENGES
ddPCR liquid biopsy’s impact on precision medicine
Dr. André Lavorato – Bio-Rad Laboratories, São Paulo, Brazil
Circulating Tumor DNA Assays in Clinical Diagnostic Tests
Dr. Elisa N. Ferreira – Grupo Fleury, São Paulo, Brazil
Discussion
4:50 - 5:00 PM
CLOSING REMARKS